New study tracks IBD drug safety for moms and babies
NCT ID NCT06337565
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 28 times
Summary
This study follows 1000 pregnant women with inflammatory bowel disease (IBD) who are taking newer medications (non-anti-TNF biologics or targeted small molecules). Researchers will track the health of mothers and their children for up to 4 years after birth, focusing on serious infections and other side effects. The goal is to provide safety data that is currently missing because pregnant women are usually excluded from drug trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUSGS FOR IBD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Universitario de La Princesa
RECRUITINGMadrid, Madrid, 28006, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.